Allen Institute reorganizes brain science division, with added focus on neural computation – GeekWire

A sculpture titled MIRALL stands sentry at the Allen Institutes headquarters in Seattles South Lake Union district. (GeekWire Photo / Kurt Schlosser)

Seattles Allen Institute is heading into a new phase of research into neuroscience a phase that includes reorganizing its current activities as well as adding new ones.

The Allen Institute for Brain Science, which is the largest division under the institutes umbrella, was established by Microsoft co-founder Paul Allen in 2003 and has continued on its mission since Allens death in 2018. Its grown to more than 300 scientists and staff members who work in two broad research areas.

One program, known as Cell Types, focuses on mapping out a periodic table of brain cells. The Allen Institutes new 16-year plan calls for the Allen Institute for Brain Science to focus solely on studying brain cell types and neural connectivity.

The second program, known as MindScope, seeks to understand how the brains neural circuits produce the sense of vision. That field of study, along with the Allen Brain Observatory, will transition out of the Allen Institute for Brain Science to become a separate program at the Allen Institute.

A new division, due for launch in 2022, will focus on research related to neural computation and dynamics.

Allan Jones, the Allen Institutes president and CEO, said the organizational changes are in line with the vision laid out by Paul Allen.

Our model has always been to find scientific problems where our particular flavor of big, team and open science can have the greatest impact, Jones said in a news release. As we shift into the next phase of our neuroscience research, I am confident that our teams will continue to push the boundaries of discovery and create invaluable resources for the community.

Hongkui Zeng, who currently serves as executive director of structured science, will lead the institutes research into brain cell types and connectivity as executive vice president and director of the Allen Institute for Brain Science.

Our teams have made incredible progress in the past decade in our quest to identify the parts lists of the mouse and human brains, and how these parts are connected into the Google map of the brain, Zeng said. Information gained from these efforts opens up unprecedented opportunities for us to look deeper into how brain works. Im excited to help bring our endeavor to the next level.

Zeng is also the principal investigator on several large research projects and programs funded by the National Institutes of Health. Shell continue to lead those projects in her new role.

Christof Koch, who is currently president and chief scientist of the Allen Institute for Brain Science, will lead the MindScope program as its chief scientist. Koch and his colleagues have spent the past eight years building the tools, recording capabilities and data analysis pipelines for the Allen Brain Observatory, which uses the mouse visual system as a model for understanding how the brain stores, encodes and processes information.

Hell continue to lead Allen Brain Observatory projects in his new role.

We are now ready over the next five years to harvest the scientific insights into how the mouse cortex, 14 million complex neurons packed into the volume of a tenth of a sugar cube, represent and evaluate incoming visual information to rapidly and robustly control the behavior and the perception of the mouse, Koch said.

The new division on neural computation and dynamics will be headed by neuroscientist Karel Svoboda, who is currently a senior group leader at the Howard Hughes Medical Institutes Janelia Research Campus in Virginia. His lab studies synaptic plasticity, and develops new technologies and tools for unraveling the mysteries of cortical functions.

Svoboda will join the institute in 2021 to help lay the groundwork for the divisions launch. He has served as a member of the Allen Institute for Brain Sciences scientific advisory councils for the past 10 years.

Over the years as a frequent visitor and advisor to the Allen Institute, I have grown to know and value its unique intellectual culture, Svoboda said. The Allen Institute has made extraordinary contributions to science and the world, and Im so excited join this amazing community.

In addition to the neuroscience groups, the Allen Institute has divisions that are devoted to cell science and immunology plus the Paul G. Allen Frontiers Group, which provides funding for researchers working on cutting-edge bioscience.

More:
Allen Institute reorganizes brain science division, with added focus on neural computation - GeekWire

There will be no prom for Susy Meza. High school seniors miss milestones amid the pandemic – Reno Gazette Journal

Buy Photo

Sparks High School senior Susy Meza poses for a portrait while wearing her junior prom dress from last year in her home on April 3, 2020. Meza, along with all high school seniors, will not be able to participate in a senior prom this year.(Photo: JASON BEAN/RGJ)

Susy's story: This is a first in a series of stories following Sparks High School senior Susy Meza. Susy, 17, will graduate in June. She is the student body president, played sports and was on the prom committee. Sheplans to study neuroscience at the University of Nevada, Reno in the fall. The next few months of high school weresupposed to be the culmination of all her hard work, and her first slow dance, before life was interrupted by the coronavirus pandemic.

Susy Meza was going to dance near a tall cardboard Eiffel Tower on Saturday night.

Instead, Susy was at home, talking to her friends about how great prom would have been.

Susy, 17, is just one the class of 2020who now marks the culmination of four years of hard work without a senior prom.

There was no "Night in Paris," the theme of this year's Sparks High prom.

Susy Meza built up the courage to ask friend Gerardo Guerrero to the Sparks High Prom that was supposed to be April 4, 2020. Instead proms across the country and for the Washoe County School DIstrict were canceled amid the coronavirus pandemic.(Photo: Provided to the Reno Gazette Journal by Susy Meza)

Susy built up the courage to ask a friend to the April 4 dance, knowing this night was going to be different.It would be at a fancy golf course instead of the school gym, and the prom committee had lined up a DJ from a popular radio station.

The centerpieces on each table would be flowers in vases filled with Orbeez that would light up.And, she was going to make sure the DJ played the 2009 Miley Cyrus hit,"Party in the USA."

"I was so excitedfor throwback songs to dance with my friends," she said.

Instead, the Washoe County School District, like those across the country, canceled promsamid the coronavirus pandemic.

The day Gov. Steve Sisolak announced that schools in Nevada would closewas the day Susy was going to shop for her prom dress.

Susy is the student body president, acheerleader, on the tennis team and was in the middle of her last season of track when everything stopped.

"I have never felt so at home in a place that's not home," Susy said of Sparks High.

She rattles off the names of almost every administrator, teacher and staff memberwho has had an impact on her life.

"The school's custodian is everyone's grandma," she said. "I miss her."

She was going to buy a gold or red prom dress, to honor the school's colors, with money she saved working at retailer Party City.

All four years of high school, she has worked a part-time job while balancing the theNational Honor Society, playing sports, student councilandclubs, including one for math, science and engineering,

But even for a remarkable high-achieving student who will study neuroscience at the University of Nevada, Reno in the fall, asking a boy to prom this year was one of her proudest moments.

Stories of kindness: How people in Reno area are helping each other amid outbreak

"I decided to break out of my shell," she said about working up the courage to ask friend Gerardo Guerrero.

She planned an elaborate prom proposal using the school's annual Mr. Sparks High School pageant, a fundraiser to buy books for children in need.The pageant is attended by the entire school and parents.She got administrators to be part of her plan.

When it came time for a teacher to interviewGerardo, she came from behind stage holding up a sign, "Handshake? Handshake. Hug? Hug. Prom? Prom."

It's an inside joke, she explained.He said yes.

"I've never gone to a dance with a date," Susy said. Last year she went with her best friend and danced the night away. But Saturday's prom was a hard night to miss.

"I was excited for my first slow dance."

CVOID-19: WCSD says learning on track despite extraordinary circumstances amid shutdown

Siobhan McAndrew tells stories about the people of Northern Nevada and covers education in Washoe County. Read her journalism right here. Consider supporting her work by subscribing to the Reno Gazette Journal.

Read or Share this story: https://www.rgj.com/story/news/2020/04/06/missing-prom-amid-covid-19-one-wcsd-sparks-high-student/2947132001/

Read more from the original source:
There will be no prom for Susy Meza. High school seniors miss milestones amid the pandemic - Reno Gazette Journal

Manchester’s world leading health research partnership extended by five years – The University of Manchester

Domains provide expert horizon scanning and strategic oversight that enable disruptive innovations to be tested and prioritised such as prevention and early detection of disease, new diagnostic tests and treatments and personalised care for patients.

MAHSC, which was first designated in 2009, also works in close collaboration with Manchesters thriving scientific community, research infrastructure and Greater Manchesters other higher education institutions.

Professor Graham Lord, MAHSC Executive Director and Vice President and Dean of the Faculty for Biology, Medicine and Health at The University of Manchester, said:We have the most advanced integrated system in the UK for aligning academic research with local health needs to speed up the translation of discoveries into patient treatments and care at scale. Taking a singular One Manchester approach, this five-year AHSC designation will enable us to enhance innovation and make faster decisions that will directly impact and improve the lives of the 2.8 million population of Greater Manchester as evidenced today by the magnificent mobilisation at pace of hundreds of researchers, scientists and health care professionals in support of efforts to fight the Covid-9 coronavirus.

Professor Peter Clayton, MAHSC Clinical Director and Chief Academic Officer, Health Innovation Manchester, said:The designation of MAHSC for a further five years is recognition of the excellence within our NHS, academic and research organisation within Manchester. The world-leading work taking place in these organisations and our domains will benefit our patients, clinicians and our wider community within Greater Manchester and beyond.

Professor Neil Hanley, Group Director of Research and Innovation at MFT, said:In the current challenging times, it is great news that Manchester has been re-designated again as an Academic Health Science Centre.

We must seize the opportunity to make maximum difference over the next five years to the health and prosperity of our local communities, to connect more deeply to our incredibly diverse and talented academic and healthcare sectors, and to fly the flag for Manchester on the national and international stage.

Raj Jain, Group Chief Executive Officer of the Northern Care Alliance and MAHSCs lead for the neuroscience domain, said:I am delighted that the Manchester Academic Health Science Centre has been re designated and will continue to work with Salford Royal, part of the Northern Care Alliance NHS Group, and other partners to improve health by giving patients and clinicians rapid access to the latest research discoveries and improving the quality and effectiveness of patient care.

Delivering excellence in research and education is a key priority for the Northern Care Alliance and our partnership with MAHSC is important as we combine our expertise to establish Greater Manchester as a world leader in health research.

Sarah Leo, Head of Research & Innovation, for Greater Manchester Mental Health NHS Foundation Trust, said:We are looking forward to continuing to collaborate with our MAHSC partners over the next five years to further enhance research and innovation activity, particularly within mental health for the benefit of our service users.

Find out more about MAHSC on our website:https://healthinnovationmanchester.com/partnerships/manchester-academic-health-science-centre/

Read the rest here:
Manchester's world leading health research partnership extended by five years - The University of Manchester

7 Scientific Pioneers Who Were Also Artistic Visionaries, From the Inventor of the Morse Code to the Founder of Neurobiology – artnet News

Art and science are often thought to fall on opposite sides of the left-right brain divide, but history has proven time and again that many of the brightest minds are polymaths.

Leonardo da Vinci, the greatest of all the artist-scientists, once wrote, To develop a complete mind: Study the science of art; Study the art of science. Learn how to see. Realize that everything connects to everything else. His suggestion is being taken even today, with many medical schools requiring soon-to-be doctors to take art and art history classes, while contemporary artists including Trevor Paglen,Anicka Yi, and Neri Oxman find influences in astronomy, biology, and geology.

Fromadventuring woman botanists to the drawing-enthused father of modern neuroscience, learn more about art historys great scientific minds below.

Maria Sibylla Merian, Metamorphosis insectorum Surinamensium (1705). Courtesy of Wikimedia Commons.

Scientific Contributions: A 17th-century naturalist and botanist, Merian was one of the first European scientists to directly observe insects. When she started her research, insects were still commonly referred to as beasts of the devil and were thought to spontaneously generate from mud. Her most influential studies detailed the metamorphosis of caterpillars into butterfliesa phenomenon that was largely undocumented before her investigations.She penned a two-volume book on caterpillars, with each accompanied by 50 plates of engravings, and is today considered one of the pioneers of the field ofentomology.

Artistic Pursuits:Before her scientific investigations,Merian first earned acclaim as a botanical artist, publishing a three-volume series, each of 12 illustrated plates of flowers, in 1675. As was common at the time, these decorative illustrations, which were not drawn from direct observation, were intended to be used by upper-class ladies as designs for embroidery, drawings, and paintings. Merians interests extended far beyond the parlor, however; an adventurer to the umpteenth degree, she traveled to Dutch Surinam on a self-funded journey in 1699 (raising many eyebrows) and documented a wealth of flora, creating some of the first color illustrations of the New World.

Samuel F. B. Morse, Gallery of the Louvre (183133). Courtesy of Terra Foundation for American Art,

Scientific Endeavors:As a student at Yale, Samuel Morse studied philosophy and math, but dreamed of a career as an artist of great history paintings. After that dream cooled, he went on to pursue his interest in the burgeoning field of electromagneticsand for the future of telecommunications, his shift in studies was a godsend. Morse would go on to develop both the telegraph and the Morse code, absolutely dazzling the world when, onMay 24, 1844, he sent the biblical line, What hath God wrought? from the US Capitol in Washington, DC, to Baltimore, with his new invention.

Artistic Pursuits: Though his career in the arts was overshadowed by his stunning accomplishments in the field of communications, Morse made a serious go at art, studying under the painter Washington Allston, and then with Benjamin West at the Royal Academy of Arts in London. Large-scale Neoclassical paintings of myth and history scenes were his passion, and the most famous of his works is the monumental Gallery of the Louvre,measuring an impressive six by nine feet. Returning to the United States, he found the American public unreceptive to his style, which he blamed on a culture of prevailing bad taste.

Ralph Eugene Meatyard, Lucybelle Crater and her 45-year-old husbands photo-Bell friends sonshine, Lucybelle Crater (1970-72). Courtesy of DC Moore Gallery.

Scientific Endeavors: Ralph Eugene Meatyard extended both of his careers, as a photographer and an optician, from a scientific and philosophical fascination with light and vision. Born in Normal, Illinois, Meatyard served in the military before becoming a licensed optician in 1949. A position with an optical firm would bring him to Lexington, Kentucky, in 1950. This firm also owned a photography company, which introduced the doctor to the medium. Profoundly influenced by Zen Buddhism (and a pen pal of the Trappist monk Thomas Merton), Meatyard would spend some three months looking through an unfocused camera to attain what he called a state of No-Focus, in which the appearance of an object was detached from its meaning.

Artistic Pursuits: Meatyard began taking photographs in the 1950s and would pursue the practice until his early death in 1972. His photographs were unusual for the time, and often included blurred figures, and, later, portraits of his children and himself wearing odd, monster-like masks. Meatyard earned little critical acclaim in his lifetime, though his works was presented alongside those of Ansel Adams, Aaron Siskind, and Harry Callahan in Creative Photography, an exhibition curated by Van Deren Coke for the University of Kentucky. His peculiar style often left him relegated to a regional style of Southern Gothic, though his posthumously published photo-book,The Family Album of Lucybelle Crater (named after the main character in Flannery OConnors short story, The Life You Save May Be Your Own), earned him increasing institutional attention.

Anna Atkins, (clockwise from top left) Peacock (1861), Laminaria phyllitis (184445), Papaver rhoeas (1861), and Alaria esculenta (184950). Courtesy of Hans P. Kraus Jr., New York (top left and bottom right); the New York Public Library, Astor, Lenox and Tilden Foundations.

Scientific Endeavors: This English botanist Anna Atkins was fascinated by the delicate and diverse varieties of algae to be found in the waterways of Great Britain. In 1843, Atkins published the first half of her scientific reference book, British Algae: Cyanotype Impressions, using light-sensitive materials to capture her specimens, thereby establishing photography as a scientific tool.

Artistic Pursuits: Atkins is regarded as the first person to publish a book illustrated with photographs and is considered by some to be the first woman to create a photograph to begin with. Moreover, she learned about the photographic process directly from her frequent correspondent Henry Fox Talbot, the man who invented the salted paper and calotype processes, the precursors to modern film photography.

Leonardo da_Vincis drawing for his aerial screw, a prototype for a helicopter with a lifting wing. Courtesy of Wikimedia Commons.

Scientific Endeavors: A true Renaissance man, Leonardo da Vinci was fascinated by anatomy, botany, astronomy, and geology, among an unending litany of other fields. Today he is best remembered for his artistic accomplishments, but his contributions to science were revolutionary and wide-reaching. He posited that the earth was not the center of the suns orbit and dissected bodies to learn the inner workings of organs and human bone structure. His notebooks are filled with inventions that could not be realized in his lifetime, including the parachute, helicopter, and even the calculator.

Artistic Pursuits: Da Vinci believed that art, science, and nature were inextricably linked and could not be fully be appreciated except in synthesisand his contemporaries and later followers seemed to agree.His paintings the Mona Lisa and The Last Supperstill drawunbelievable crowds, and his sketch of theVitruvian Man,another cultural touchstone, is perhaps the best representation of his belief that scientific study could reveal harmony and proportion in the universe.

Santiago Ramn y CajalsCalyces of Held in the nucleus of thetrapezoid body (1934). Courtesy of Cajal Institute (CSIC), Madrid.

Scientific Contributions: TheSpanish-born Cajal has been called the father of modern neuroscience, and in 1906 won the Nobel Prize for his revolutionary research into the nervous system. He was the first person to suggest that the brain is composed of individual cell structures, and his contributions to the understanding of how the brain actually works are still studied today.

Artistic Pursuits: Cajal aspired to be an artist before his father encouraged him to pursue medicine, but his initial passion never waned. During his career, he made thousands of detailed drawings of brain matter based on what he saw through microscopes, and today these drawings remain valued sources for neurological study. His images range in style from Vienna Secession-inspired tree-like branches of the nervous system to inky, amorphic images of neurons.

John James Audubon, American Flamingo from The Birds of America. Courtesy of the Field Museum, Chicago.

Scientific Endeavors:Ornithologists around the world revere his name to this day.John James Audubon was born in Haiti and raised in France, then immigrated to Pennsylvania at the age of 18. His love of birds translated into an impassioned and scientific pursuit, as he studied their migratory habits and depicted them realistically in their habitats. He traveled the US endeavoring to depict all the birds in the county and was Americas leading wildlife artist for half a century. The Audubon Society is named after him and is inspired by his mission.

Artistic Pursuits:Audubons depictions of birds were far from purely scientific. He depicted his creatures with delicacy, color, and often bits of flora for their habitats. His Birds of America, a collection of 435 life-size prints, remains the standard for wildlife artistry. An early copy of the mammoth book sold for $11.5 million at Sothebys in 2010.

See the article here:
7 Scientific Pioneers Who Were Also Artistic Visionaries, From the Inventor of the Morse Code to the Founder of Neurobiology - artnet News

Where We Are Investing Now: Life Sciences, Part 1 – AlleyWatch

Life Sciences are the heart of health. New approaches in bio, microbiome, treatments, disease prevention, neuroscience, and pharma propel transformation in care. As such, life sciences stand at the heart of our funds focus on individual health and happiness.

We have been investing in life sciences since 2016 when we started Joyance, our initial health-focused fund. But this year, we are going to take it up a notch.

We have deepened our deep science team. Jun Deng (PhD in Physiology), our first hire for Joyance, continues to lead our bio practice from Silicon Valley. Jun has been joined by Neha Tanna (MD/MBA) in London, as well as Michio Painter (PhD in Immunology) and Emilia Gonzalez (Harvard bioscientist) in Boston. This Gang of Four has completely rethought our approach to life sciences.

For an early and relatively small fund like ours, the key to successful life sciences investing is picking out potential winners early. Unlike other areas of investing, in Life Sciences, a company can drop to zero in value quite suddenly, after millions of dollars are expended. A treatment that worked great in the lab, and in mice and pigs, can show unexpected side effects or simply fail to work or in humans. This is dangerous investment territory. Even if things go well, it can take literally decades for a new Life Sciences approach to make the market. We are a 10-year fund that invests at inception, so those long lead times are problematic.

So, what will we do?

The watchword for our funds in life sciences is Discipline.

For 2020, we will organize Life Sciences into three sectors: Digital Health, Pharma, and Medical Devices. Our approach to each of these will be different. In this post, well look at how we organize these areas. The next post digs into the new investing frameworks weve developed.

Digital Health

The primary Life Sciences focus area for both of our funds will be Digital Health.Digital Health, broadly defined, is the convergence of digital technologies with health, healthcare, daily life, and society to enhance the efficiency of healthcare delivery and make delivery of prevention and care personalized and precise.

We only want to invest in digital health companies that address large pain points, have the potential for dramatic impact on patient/consumer outcomes, and have clear business models.

Our investments will target consumers, providers, or payers as the sources of revenue, in that order.

Our Digital Health focus areas for 2020 will be:

Healthcare-enabling technology

Major chronic diseases

Neurotech

Mental health and happiness

Nutrition and fitness

Femtech

Boomer economy/Senior care

Digital Health will be the primary Life Sciences focus area for Joyance. Digital Health is a powerful way for science to deliver Delightful Moments, which is Joyances singular target. Delightful Moments shift individuals, for at least a short time, out of the daily humdrum and toward greater joy, calm, comfort, absence of anxiety, absence of pain.

Social Starts will focus on Digital Health alongside the other deeper bioscience, pharma, and medical device areas described below. Our new Social Starts fund, Social Starts Health and Happiness, will bring resources and attention to therapeutics, pharma, and biologics we have never had before.

Our approach to Digital Health will be encompassing. We will find and evaluate many companies. Because digital health startups can achieve revenue quickly, we can evaluate these companies using tools similar to those we use for CPG.

Pharma/Biotech/TherapeuticsSocial Starts will be exceedingly disciplined yet maximize investments in pharmaceuticals, therapeutics, and biotechnologies that address a large consumer pain point, have a defined lead asset, a <24-month path to Series A, display a strong human rationale and address an obvious clinical need. Joyance will invest in these areas rarely, only when Delightful Moments emerge from clinical development.

For 2020, our Pharma/Biotech/Therapeutics focus will be:

Microbiome: When there are clear indications and evidence for species/strain value and level of importance.

Oncology: Space may be an opportunity only if the approach is novel, as it is a crowded area.

Neuro: Worth exploring, but we need to be stringent in following our rules, as there are very high failure rates.

Metabolic, cardiovascular, infectious disease, vaccines, and ophthalmology: Also worth exploring, as they have the highest approval rates from the FDA.

We need to avoid:

Big platform plays with little evidence, as they are capital intensive from the start and have long timelines.

Longevity, as the field is not mature enough; though we should watch this area and pounce when real evidence emerges.

We should work hard to uncover deep science companies in these areas. In deep science bio, though, it doesnt matter if we evaluate 500 companies and invest in only none. In every case, our task is to apply our filters and only move forward when startups completely satisfy our requirements. Charisma doesnt count in pharma/therapeutics. The market wont matter if the science doesnt work.

Medical Devices

Due to long trajectories, lack of exit paths, and heavy regulation, we will be hyper-selective in medical device investment. We will focus on medical device companies that address a large problem, have high barriers (e.g., De novo / PMA), and have veteran teams in their areas.

We will look for appropriate medical devices in these areas for 2020:

We are looking for next-generation medical devices that recognize the increasing patient-centricity of care. Merely improving the performance of current devices/technologies is not sufficient. Devices that can only operate within institutional settings are much less interesting to us than those that can bring care closer to the lives of people.

This three-part approach allows us to evaluate life sciences flexibly. This is a vast area of science and innovation. We need to adapt what we do to the characteristics of the divergent aspects of life sciences.

Reprinted by permission.

View post:
Where We Are Investing Now: Life Sciences, Part 1 - AlleyWatch

Keep dreaming – Thrive Global

Today is a great day to practice shifting the focus from all the heaviness of late.

I am reminded of one of my favorite parenting memories. When my kids were little, as I tucked them in at night after reading a book, I would ask them: What was the best part of your day? It was an intuitive question.

I did not know then what I have since learned decades later as a coach trained in neuroscience: The most critical times of the day for focusing on empowering thoughts and beliefs are the first five minutes upon waking and the five minutes before going to sleep at night. And if you are agitated, you would fare better if you got up out of bed and walked around rather than trying to force yourself to sleep, according to the late Dr. Wayne Dwyer.

Think of it this way in terms of computers: You are downloading your thoughts (the software) that will circulate throughout your mind (the hardware) while sleeping. YOU CAN CHOOSE YOUR THOUGHTS. Thoughts of gratitude are known to shift mindsets. Everyone can find three to five things for which they are grateful.

Most importantly, get unplugged. I admit a couple of weeks ago I initially spent too many hours watching the news before choosing instead to use that time to be creative or to get quiet, meditate or pray.

Yesterday I made another commitment to elevate my mindset to a greater state of well-being. I chose first thing in the morning to keep dreaming about my ideal life and bringing forth my new platform around worthiness. I have a big mission, which I consider my legacy, around this dream. There are a lot of pieces now in the works behind-the-scenes that I will soon be sharing.

So, instead of watching the news or rushing to social media, or even meditating first thing in the morning, I did something totally different. I took my vision boards of the past four years and displayed them all around my bedroom. Upon waking, I now see my dreams, many of which have come true or are in development.

Rather than feel constricted by all the news of late, I switched my focus. My most recent board features the above photo of open doors, pasted in the center, to help keep my mind expanded into unlimited possibilities.

If you would like to learn more about visualizing your dreams, email me at [emailprotected],and I will send you a free handout that outlines tips for manifesting anew.

Your dreams matternow more than ever. We each have a unique gift to offer the world. Know you are worthy of finding and delivering it.

With love and blessings,

Gail

P.S.And if you want to do something proactive during this time to support those on the front lines who do not have the luxury of focusing on their dreams right now,click on this link.

This post was originally published at SupportMatters.com.

Read more here:
Keep dreaming - Thrive Global

Sonnet BioTherapeutics Announces Formation of Scientific Advisory Board – Yahoo Finance

PRINCETON, NJ / ACCESSWIRE / April 6, 2020 / Sonnet BioTherapeutics Holdings, Inc. (SONN), a biopharmaceutical company developing innovative, targeted biologic drugs with enhanced single or bispecific mechanisms of action, announced today the formation of its Scientific Advisory Board. The Board comprises experts from leading institutions across the United States, including MD Anderson, Memorial Sloan-Kettering, Fox Chase and Robert Wood Johnson. The members bring decades of experience in oncology, neurology, drug discovery and clinical development.

"Sonnet is privileged to have this distinguished group of scientific advisors from leading institutions to help guide our clinical development and discovery programs," commented Sonnet Founder and CEO, Pankaj Mohan, Ph.D. "The advisors come to the company after reviewing its assets and are excited to be a part of the team. They share deep experience in oncology drug development from initial discovery to late-stage clinical studies, which will enhance our strategic efforts through the next phase of growth."

Sonnet Scientific Advisory Board members include:

Jason Bock, Ph.D., - Dr. Bock is the Vice President and Head of Biologics Product Development at MD Anderson Cancer Center. In this role, Dr. Bock works with MD Anderson's Therapeutic Discovery team, including world-class oncology researchers and clinicians, to create life-saving transformational medicines quickly, safely and effectively. Before joining MD Anderson, Dr. Bock spent 20 years in small, medium and large biotech and biopharma companies (including Human Genome Sciences, CoGenesys and TEVA) developing biologic therapeutics. He has brought 15 novel drugs through preclinical development into clinical studies and has guided the process to bring three biologics through the clinic and to commercialization globally. He received his Ph.D. from Stanford University in Molecular & Cellular Physiology.

Joseph R. Bertino, M.D., - Dr. Bertino is University Professor of medicine and pharmacology, UMDNJ-Robert Wood Johnson Medical School and is the interim director of the school's Cancer Institute of New Jersey. Dr. Bertino joined The Cancer Institute of New Jersey in 2002 as associate director and was appointed chief scientific officer in 2004. Previously, Dr. Bertino served as chair of the Molecular Pharmacology and Therapeutics Program, and member and co-head of the Program in Developmental Therapy and Clinical Investigation at Memorial Sloan-Kettering Institute for Cancer Research. Dr. Bertino has been internationally recognized for his role in finding curative treatments for leukemia and lymphoma. He is the author or co-author of more than 400 scientific publications and the associate medical editor of the journal Hem/Onc Today. After earning his medical degree, Dr. Bertino did a USPHS fellowship in hematology and oncology at the University of Washington School of Medicine.

Hossein Borghaei, D.O., M.S., - Dr. Borghaei is Chief of Thoracic Medical Oncology at Fox Chase Cancer Center, where he is also a Professor in the Department of Oncology/Hematology, Co-Director of the Immune Monitoring Facility and the Gloria and Edmund M. Dunn Chair in Thoracic Malignancies. In his clinical practice, Dr. Borghaei has participated in numerous immunotherapy-based clinical trials. He is also the principal investigator (PI) of a laboratory that develops new monoclonal antibodies and novel immune-modulating drugs. He served as the PI of a phase III randomized study that proved the effectiveness of nivolumab in the treatment of patients with advanced non-squamous non-small cell lung cancer after progression on prior chemotherapy. This work led to the approval of nivolumab, one of the first immunotherapy-based drugs to be approved for lung cancer in this setting. Dr. Borghaei earned his D.O. degree at Philadelphia College of Osteopathic Medicine, did his residency at Graduate Hospital (Philadelphia) and was Chief Fellow, Hematology-Oncology, at Fox Chase Cancer Center.

Guido Cavaletti, M.D., - Dr. Cavaletti is Dean of Research and Professor at the University of Milan-Bicocco, and Senior consultant neurologist and head of the Neuroimmunology Center, S. Gerardo Hospital, Monza (Italy). At the University of Milan-Bicocco, he is Head of the Experimental Neurology Unit at the School of Medicine and Surgery and Director of the Ph.D. program in Neuroscience. He is also Deputy Scientific Director of the Milan Center for Neuroscience (NeuroMI). Dr. Cavaletti is coordinator of the steering committee of the international CI-PeriNoms group on the investigation of chemotherapy-induced peripheral neurotoxicity. He has authored more than 250 peer-reviewed papers. He received his medical degree from the University of Milan and is Board-certified in Neurology.

Story continues

About Sonnet BioTherapeutics Holdings, Inc.

Founded in 2011, Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bispecific action. Known as FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and "hitch-hikes" on human serum albumin (HSA) for transport to target tissues. FHAB is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies and vaccines.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions.

These statements may be identified by the use of forward-looking expressions, including, but not limited to, "expect," "anticipate," "intend," "plan," "believe," "estimate," "potential, "predict," "project," "should," "would" and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company's filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Sonnet Biotherapeutics Investor Contact

Alan LadaSolebury Trout617-221-8006alada@soleburytrout.com

SOURCE: Sonnet BioTherapeutics Holdings, Inc.

View source version on accesswire.com: https://www.accesswire.com/583990/Sonnet-BioTherapeutics-Announces-Formation-of-Scientific-Advisory-Board

Go here to read the rest:
Sonnet BioTherapeutics Announces Formation of Scientific Advisory Board - Yahoo Finance

Research finds similarities between the way humans, chimpanzees age – UNM Newsroom

A team of researchers from The University of New Mexico, working with the Kibale Chimpanzee Project in Uganda, have found similarities in the way chimpanzees and humans age. In their recently published paper, Wild chimpanzees exhibit humanlike aging of glucocorticoid regulation, the researchers relate findings of their decades-long study.

The New Mexico team is led by associate professor of Anthropology and co-director of the Comparative Human and Primate Physiology Center Melissa Emery Thompson. Other team members are Ph.D. candidates Stephanie A. Fox, Sarah Phillips-Garcia, Drew K. Enigk, and Kris Sabbi, evolutionary anthropologist Andreas Berghnel, and associate professor of Anthropology and co-director of the Comparative Human and Primate Physiology Center Martin N. Muller.

The research group has studied a community of about 55 wild chimpanzees in Kibale National Park, Uganda, for the past 32 years. They are currently trying to understand the aging process in chimpanzees and how it compares with that in humans.

Chimpanzees can live past the age of 60 in the wild and are human's closest living relatives, so the reason for this comparison is to determine which aspects of aging are unique to the human species, or not, Emery Thompson explained. This kind of research may help provide clues as to what factors shaped the prolonged human lifespan, as well as the extent to which aging processes are influenced by environment. As an example, neither chimpanzees nor humans living in small-scale subsistence groups are susceptible to atherosclerosis (clogged arteries), suggesting that it may be the unusual diets and activity levels of industrialized societies that places us at risk.

Cortisol is the key product of the stress response and plays an essential role in energy metabolism. But, high levels of cortisol contribute to many of the degenerative processes of human aging, including bone loss, cardiovascular disease, immunosenescence, which is the gradual deterioration of the immune system brought on by natural age advancement, and cognitive impairments.

Emery Thompson explained that this problem is exacerbated because the system that regulates cortisol production wears out as humans age, so the amount of cortisol we produce increases, along with its negative consequences.

We found strong evidence that a similar kind of dysregulation occurs in chimpanzees. Their levels of cortisol increased with age, and this could not explained by changes in social status or reproductive activity. Like humans, chimpanzees have a circadian rhythm of cortisol production with a peak early in the morning followed by a decline throughout the day. We found that aging chimpanzees had a blunted circadian rhythm, paralleling an important feature of aging in humans, Emery Thompson said.

In order to study the cortisol levels in the chimpanzees, the team members had to collect urine samples from the primates.

Most people want to know how we collect urine, Emery Thompson laughed. Chimpanzees spend about half of their day up in the trees, where they find most of their food. They also sleep in the trees in nests they make from branches.

Our research staff uses catchpoles fashioned from forked sticks with small plastic bags on the end to collect the urine as it falls. Like people, chimpanzees usually pee just after they wake up and when they are leaving one location to go to another. We go out before dawn to make sure we find the chimpanzees in their nests and collect urine just as they are beginning their day. Since 1998, we have collected over 40,000 urine samples from this one group of chimpanzees. We can use these samples to monitor reproductive function, stress, energetic condition, lean body mass, hydration, and indicators of health.

Many of the same things that stress humans also stress the chimpanzees.

Chimpanzees live in complex social networks, which can cause all kinds of stress as individuals compete for food, status, and mating opportunities, Emery Thompson noted.

In our study, male chimpanzees with high rank had higher cortisol levels, which is the opposite of the pattern in humans where high status is less stressful. But, high-ranking chimpanzee males expend a lot of energy in status displays and engage in high rates of aggression. We also found that male chimpanzees had higher cortisol when there was a sexually receptive female present. Females get large swellings of their genital skin for 10 to 12 days around the time of ovulation, and this instigates a lot of competition among the males.

The males arent the only ones stressing during this time.

We also found that this was stressful for the females being competed over, as males not only fight with each other, but intimidate and harass the females. Females with swellings often have males bugging them all day long, so they also don't get to feed as much.

In many primate studies, seasonal food shortages are stressful, as are periods when females are nursing young infants, because their energetic demands increase.

However, we did not find that here. Kibale National Park is a high-quality habitat for chimpanzees, and the area we work in has improved over the 30 years of the project because the forest, which was previously logged, has regenerated, Emery Thompson said.

Researchers expected that older males would produce a higher cortisol response when competing for mates and status, but they did not, perhaps because older males pursue less risky behaviors. They had also expected that high cortisol would indicate an increased cost of nursing infants for older females, because this is so energetically taxing. Again, this was not the case. Instead, females produced the most cortisol when they were sexually receptive, a time when they are exposed to a lot of aggression, both attacked by males and are near a lot of males competing over them. This effect did increase with age. Older females experienced disproportionately more stress when they were sexually receptive.

Taken together, our results indicate that dysregulation in production of cortisol is a common pathway for aging in both humans and chimpanzees. This suggests that humans inherited this feature, and it is neither a byproduct of our extended lifespans nor our unusual modern environments. What is not yet clear is whether humans and chimpanzees differ in the effects of cortisol on age-related disease. We are currently examining a number of other features of aging such as immune function, physical frailty, social behavior, and fertility to try to build a cohesive picture of chimpanzee aging, Emery Thompson explained.

Despite collecting the chimps urine every day, researchers maintain their distance from them, unlike the renowned primatologist and anthropologist Jane Goodall, who is often portrayed in photos and documentaries interacting and even hugging the chimps.

In fact, no field studies do that anymore. We maintain a distance of at least 15 feet from the chimpanzees at all times. Because we are interested in their natural behavior, our goal is that they go about their business without interacting with or worrying about us. We also do that for the chimpanzees' protection. Cold and flu viruses from humans are extremely dangerous for great apes because they are closely enough related to us that the same viruses infect them, but they do not have acquired immunity to these viruses, so they have a high risk of death if infected. We have largely suspended research activities in light of COVID-19, Emery Thompson noted.

One of the biggest limitations the research team faces is that they are studying an endangered species in the wild, meaning that everything they do has to be non-invasive.

We cannot weigh animals, conduct direct exams, or collect blood samples. And since the animals are not in cages, we have to go out and find them every day, and if they die, we may never locate them. This means we have very little understanding of how older chimpanzees die. On the other hand, it is clear that aging is affected by the environment and by lifestyle, so it is essential to understand how a species ages 'naturally' in the kind of environment in which it normally lives. Our study necessarily involves fewer subjects than a typical human clinical study, but it features much more comprehensive sampling of individuals, both for cortisol and for features of the social and physical environment.

Like much of the rest of the world, the researchers are isolating from the world, including the chimpanzees.

Uganda is now closed off due to COVID-19, so all of our foreign researchers have gone home. I typically visit one or two times a year, as do my fellow co-directors, including Martin Muller. Our Ph.D. students conduct field research for longer stints, typically six to 18 months, Emery Thompson said.

The chimpanzee study will bring new insight into aging in humans, she concluded.

Most research on aging is targeted either at curing the diseases of aging, such as heart disease, or treats aging itself as a disease. We are addressing an underdeveloped area of research on the basic biology of aging. While this might not lead to extension of the human lifespan, understanding how our aging pattern evolved can help us to figure out how to age more successfully. This is just one piece of the puzzle, but we are interested in sorting out which features of aging humans have in common with our closest relatives, which are unique to humans and their extended lifespan, and which are unnatural products of living in industrialized environments.

See the original post here:
Research finds similarities between the way humans, chimpanzees age - UNM Newsroom

Connect Health teams up with EQL on digital physiology triage app – LaingBuisson

Integrated community musculoskeletal services provider Connect Health has teamed up with EQL to offer enhanced AI triage for its physiotherapy patients. Under the deal, Connect Health patients will be able to access PhysioNow an AI-enabled triage applicationbased on EQLs Phio app, that provides support and self-management while identifying and evaluating the right treatment pathway.

Log In Subscribe Now

Maria has more than two decades' experience as a business and financial journalist. She has specialised in writing about the UKs private and voluntary healthcare sector for the last 15 years. Maria covered the historic Condordat signed by the NHS and independent healthcare providers, which paved the way for the Labour governments radical market-based reform of the NHS at the turn of the Millennium. Since then, she has tracked the key trends in independent healthcare from the advent of patient choice and the emerging NHS market to multi-million pound flotations and game-changing deals.

See the original post here:
Connect Health teams up with EQL on digital physiology triage app - LaingBuisson

Five BHS swimmers garner national honors – Burlington Hawk Eye

AbouAssaly, Macomber, Geiger, Hellman, Mohrfeld recognizedby National Interscholastic Swimming Coaches Association of America.

The high school boys swimming season has been over for almost two months now and the girls season ended in early November, but the accolades keep rolling in the the Burlington High School swim teams.

Five Grayhounds three boys and two girls were recently selected to the National Interscholatstic Swimming Coaches Association of America Academic All-American team.

Elena AbouAssaly and Sarah Macomber were selected for the girls team, while Colby Geiger, Wyatt Hellman and Jacob Mohrfeld represent the BHS boys.

In order to qualify for selection, a student-athlete must meet the time requirements in their swimming events and maintain at least a 3.75 grade-point average.

Im so excited about this. Its so cool that we had the opportunity to apply for this, said AbouAssaly, who is planing to major in physiology with a minor in music at the University of Iowa. Its really cool that we have so many seniors eligible to apply for it and get it.

I wasnt even aware of it until a couple days ago when I got an email, said Hellman, a senior at Holy Trinity Catholic High School in Fort Madison. Considering I didnt start swimming until my freshman year and I spent that year swimming at the YMCA, thats a pretty big accomplishment. I only swam three years for Burlington ad I showed a lot of improvement. I think it was worth quitting basketball for.

I was really proud of all of my girls, BHS girls swim coach Mark Shepherd said. Its always tough when you are out for a sport to keep your head in the game and keep up good grades in the classroom. Thats a good job on their part.

All five student-athletes had to learn to manage their time wisely to find success both in the classroom and in the pool.

I really enjoyed my sport, but being able to keep up my grades and being an All-American is a great honor, said Geiger, who is set to enter the CNC programming field of study at Southeastern Community College. You learn early on how to manage your time to get your homework done. Every night I had homework, I tried not to plan anything so I could go home right after practice and do my homework. I tried to get as much done in school as I could, especially on nights when we had meets.

Academically I took classes at Holy Trinity, but i also took some courses at Burlington and a couple at Fort Madison, Mohrfeld said. I have even been taking some automotive classes at SCC this year. I took a good mix of people to be successful.

It says a lot about those three individuals, BHS boys swim coach Jeff Kristensen said. Their work ethic in and out of the pool is tremendous. But that's also true about many student-athletes as we've see with the recognition of teams recently for their overall GPAs. It's an award that looks at their individual cumulative grade-point average for four years of high school. It's tough to maintain that grade-point average with all the other distractions they have.

See the original post here:
Five BHS swimmers garner national honors - Burlington Hawk Eye